Repro Med Systems, Inc. (KRMD): Price and Financial Metrics
KRMD Price/Volume Stats
Current price | $2.36 | 52-week high | $4.48 |
Prev. close | $2.28 | 52-week low | $1.98 |
Day low | $2.25 | Volume | 239,500 |
Day high | $2.49 | Avg. volume | 93,320 |
50-day MA | $2.13 | Dividend yield | N/A |
200-day MA | $2.51 | Market Cap | 107.88M |
KRMD Stock Price Chart Interactive Chart >
KRMD POWR Grades
- Sentiment is the dimension where KRMD ranks best; there it ranks ahead of 94.8% of US stocks.
- The strongest trend for KRMD is in Quality, which has been heading up over the past 26 weeks.
- KRMD's current lowest rank is in the Momentum metric (where it is better than 7.41% of US stocks).
KRMD Stock Summary
- KRMD has a market capitalization of $101,842,677 -- more than approximately just 20.06% of US stocks.
- The ratio of debt to operating expenses for KORU MEDICAL SYSTEMS INC is higher than it is for about just 19.14% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.3 for KORU MEDICAL SYSTEMS INC; that's greater than it is for only 17.4% of US stocks.
- Stocks that are quantitatively similar to KRMD, based on their financial statements, market capitalization, and price volatility, are DIBS, ANIK, BMRA, RPID, and AEYE.
- Visit KRMD's SEC page to see the company's official filings. To visit the company's web site, go to www.korumedical.com.
KRMD Valuation Summary
- KRMD's price/sales ratio is 3.9; this is 7.14% lower than that of the median Healthcare stock.
- KRMD's EV/EBIT ratio has moved down 5.4 over the prior 243 months.
Below are key valuation metrics over time for KRMD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
KRMD | 2023-12-29 | 3.9 | 4.1 | -13.6 | -10.3 |
KRMD | 2023-12-28 | 3.7 | 3.8 | -12.8 | -9.7 |
KRMD | 2023-12-27 | 3.9 | 4.1 | -13.6 | -10.3 |
KRMD | 2023-12-26 | 3.9 | 4.0 | -13.5 | -10.2 |
KRMD | 2023-12-22 | 3.8 | 4.0 | -13.2 | -10.0 |
KRMD | 2023-12-21 | 3.8 | 4.0 | -13.3 | -10.1 |
KRMD Growth Metrics
- Its 2 year cash and equivalents growth rate is now at 203.96%.
- Its 3 year cash and equivalents growth rate is now at 448.35%.
- Its 3 year price growth rate is now at 74.56%.
The table below shows KRMD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 27.04186 | -7.458145 | -7.752773 |
2022-06-30 | 25.32201 | -6.168674 | -7.620991 |
2022-03-31 | 24.30355 | -3.465929 | -5.824199 |
2021-12-31 | 23.49018 | -4.31951 | -4.562823 |
2021-09-30 | 21.05689 | -5.314138 | -4.329093 |
2021-06-30 | 21.09666 | -6.227022 | -2.98614 |
KRMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- KRMD has a Quality Grade of D, ranking ahead of 19.43% of graded US stocks.
- KRMD's asset turnover comes in at 0.501 -- ranking 94th of 186 Medical Equipment stocks.
- CSII, NVRO, and XENT are the stocks whose asset turnover ratios are most correlated with KRMD.
The table below shows KRMD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.501 | 0.601 | -0.483 |
2021-03-31 | 0.531 | 0.618 | -0.535 |
2020-12-31 | 0.646 | 0.618 | -0.188 |
2020-09-30 | 0.852 | 0.630 | -0.036 |
2020-06-30 | 1.170 | 0.634 | 0.047 |
2020-03-31 | 1.753 | 0.636 | 0.245 |
KRMD Price Target
For more insight on analysts targets of KRMD, see our KRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $5.17 | Average Broker Recommendation | 1.83 (Hold) |
Repro Med Systems, Inc. (KRMD) Company Bio
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
Latest KRMD News From Around the Web
Below are the latest news stories about KORU MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate KRMD as an investment opportunity.
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare ConferenceMAHWAH, N.J., November 29, 2023--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023. |
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023MAHWAH, N.J., November 28, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced it will host an investor day at the Mahwah, NJ headquarters on Tuesday, December 5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time. The event will include |
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call TranscriptKORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript November 8, 2023 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.04. Operator: Good day. And welcome to the KORU Medical Systems Third Quarter 2023 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note this conference […] |
The past three years for KORU Medical Systems (NASDAQ:KRMD) investors has not been profitableFor many investors, the main point of stock picking is to generate higher returns than the overall market. But in any... |
KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year OutlookChallenges in Novel Therapies and Domestic Core Markets Lead to Revised Full Year Guidance |
KRMD Price Returns
1-mo | 10.28% |
3-mo | -3.87% |
6-mo | -12.59% |
1-year | -43.74% |
3-year | -32.38% |
5-year | 47.50% |
YTD | -3.87% |
2023 | -31.23% |
2022 | 19.00% |
2021 | -50.17% |
2020 | -7.81% |
2019 | 295.76% |
Loading social stream, please wait...